We strive to create a healthier future through brave scientific pursuits.

Clinical trials play a critical part in the R&D of new medical treatments to ensure their safety and efficacy.

AIT’s clinical trials are conducted by experienced, trained professionals, who are dedicated to planning and conducting clinical trials safely and in accordance with all necessary regulatory guidelines. We have in-house CRA and medical supervisors and advisors that assist us.

AIT’s Clinical Trial Pipeline

ProductIndicationPre-ClinicalPhase 1Phase 2Phase 3Status
RSV (Bronchiolitis)
First Phase 3 trial to be completed in 2017
Non Tuberculosis Mycobacterium (NTM) & CF
Phase 2 to be completed in 2017
Chronic Obstructive Pulmonary Disease
Phase 2 to be completed in 2018
CF Exacerbation
Cystic Fibrosis (CF) Exacerbation
Phase 2 to be completed in 2017